El riesgo de infarto de miocardio no fatal en los siguientes 30 días tras revascularización coronaria percutánea es menor con abciximab que con tirofibán
The risk of a non-fatal myocardial infarction in the first 30 days after percutaneous coronary revascularization is lower with abciximab than with tirofiban
Read
1879
Timeswas read the article
702
Total PDF
1177
Total HTML
Article information
ISSN: 02105691Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 2 | 4 |
| 2025 5 | 70 | 20 | 90 |
| 2025 4 | 207 | 21 | 228 |
| 2025 3 | 45 | 18 | 63 |
| 2025 2 | 56 | 35 | 91 |
| 2025 1 | 46 | 47 | 93 |
| 2024 12 | 35 | 32 | 67 |
| 2024 11 | 45 | 56 | 101 |
| 2024 10 | 30 | 51 | 81 |
| 2024 9 | 45 | 20 | 65 |
| 2024 8 | 40 | 41 | 81 |
| 2024 7 | 34 | 22 | 56 |
| 2024 6 | 51 | 26 | 77 |
| 2024 5 | 28 | 24 | 52 |
| 2024 4 | 31 | 21 | 52 |
| 2024 3 | 41 | 24 | 65 |
| 2024 2 | 40 | 39 | 79 |
| 2024 1 | 42 | 35 | 77 |
| 2023 12 | 40 | 36 | 76 |
| 2023 11 | 42 | 16 | 58 |
| 2023 10 | 39 | 16 | 55 |
| 2023 9 | 33 | 30 | 63 |
| 2023 8 | 27 | 11 | 38 |
| 2023 7 | 64 | 36 | 100 |
| 2023 6 | 27 | 8 | 35 |
| 2023 5 | 17 | 15 | 32 |
Show all
